Medical cannabis conference coming to Sydney
iCAN: Israel-Cannabis has announced CannaTech AU, a global medical cannabis summit set to take place in Sydney in October.
Following on from the success of the company’s CannaTech Israel Summit, CannaTech AU will highlight industry thought leaders from Australia and around the world who are known for their contributions to the global medical cannabis market in all fields. The event will cover a wide breadth of the most current industry topics, including presentations that range from medical science to technology to investment to international regulation and more.
“Australia is a key and growing player in the exploding cannabis field,” said Saul Kaye, founder and CEO of iCAN:Israel-Cannabis. “Many Australian cannabis companies are on the cutting edge of the market and we are thrilled to bring some of the world’s leading companies and investors to Australia to meet with their counterparts to discuss a range of business and technological issues.
“As a native Aussie myself, I could not be prouder to bring CannaTech to my country of birth and work with like-minded professionals who understand the immense global health and business potential of medical cannabis moving forward.”
The event will see iCAN partner with Australia’s first medical cannabis accelerator, BuddingTech. The latter’s CEO, Adam Miller, said he was excited to be part of Australia’s first medical cannabis conference of international scale.
“Australia is well positioned to become a world leader in the production, manufacturing and export of cannabis due to its strong workforce, high-level academic and research capabilities, and well-developed agricultural skills,” said Miller. “CannaTech will allow us to showcase our capabilities in this burgeoning industry.”
The event will take place from 23–24 October at Doltone House Jones Bay Wharf, Pyrmont. For more information, visit https://www.canna-tech.co/sydney-2018/.
Professor Tony Haymet appointed Australia's Chief Scientist
Emeritus Professor Tony Haymet — a world-leading oceanographer, chemist and entrepreneur...
NZ announces significant reforms to science sector
The reforms are intended to maximise the value of the $1.2 billion in government funding that...
Vaxxas to advance its microarray patches for COVID vaccination
Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...